神州细胞: insider trades · France · AMF SSE:688520 FR FR · AMF Mcap 19.3Bn€
Discover the full insider trade history of 神州细胞, a listed equity based in France. Shares are quoted on FR FR, under the authority of AMF. Market capitalisation: €19.3bn. The latest transaction was disclosed on 5 July 2022 — Purchase. Among the most active insiders: 谢良志. All data is free.
Financial data FY ended December 2025 · cache
Income statement
Revenue 1.56 Bn€
Gross profit 1.45 Bn€ 93% margin
Net income −564.9 M€ -36.2% margin
Balance sheet & cash
Market cap 19.29 Bn€
Total debt 3.13 Bn€
Free Cash Flow −492.1 M€
Last declaration on 5 July 2022
Declarations 7 total
Executives ● Purchase22 SSE
180,000 shares
SSE:173000005652000060 · 5 Jul 2022
Ideal exit: 1 Apr 2023 (T+270) Executives ● Purchase7 SSE
63,000 shares
SSE:173000005648954050 · 4 Jul 2022
Ideal exit: 31 Mar 2023 (T+270) Executives ● Purchase7 SSE
50,000 shares
SSE:173000005640886900 · 1 Jul 2022
Ideal exit: 28 Mar 2023 (T+270) Executives ● Purchase7 SSE
70,000 shares
SSE:173000005636176260 · 30 Jun 2022
Ideal exit: 27 Mar 2023 (T+270) Executives ● Purchase7 SSE
60,000 shares
SSE:173000005621912450 · 28 Jun 2022
Ideal exit: 25 Mar 2023 (T+270) Executives ● Purchase7 SSE
55,000 shares
SSE:173000005618588500 · 27 Jun 2022
Ideal exit: 24 Mar 2023 (T+270) Executives ● Purchase7 SSE
8,000 shares
SSE:173000005614885540 · 24 Jun 2022
Ideal exit: 21 Mar 2023 (T+270)